Cancer Statistics in Hong Kong: The Need for Early Detection

 

According to 2022 statistics from the Hong Kong Cancer Registry under the Hospital Authority, there were 35,373 new cancer cases in Hong Kong, averaging 97 daily diagnoses. Cancer incidence rates per 100,000 population were 482 overall, with males (514) slightly higher than females (454). The top five cancers—lung, breast, colorectal, prostate, and liver cancers—accounted for 58% of all new cases. Despite advancements in treatment, late-stage diagnoses remain a critical challenge, underscoring the urgent need for Early Cancer Detection strategies.

 

What is a CTC test?

The CTC test (Circulating Tumor Cell Test) is an innovative cancer screening method that detects cancer cells in the bloodstream before tumors are visible on imaging scans. This test is particularly effective for identifying cancer at its earliest stages, such as when tumors are smaller than 6 mm.

 

How is CTC test Done?

The CTC test involves a simple blood draw, where a sample is analyzed for the presence of circulating tumor cells (CTCs). These cells are released into the bloodstream as cancer progresses, making them a key biomarker for early detection.

 

How Accurate is the CTC test?

A 2015 study by Papasotiriou et al. demonstrated that the CTC test achieves 86.2% sensitivity and 83.9% specificity across various cancers, including breast, prostate, pancreatic, colon, and melanoma. This high accuracy makes it a reliable tool for Early Cancer Detection.

 

Key Benefits of the CTC Test

 

1. Early Cancer Detection

The CTC Test can identify cancer at its earliest stages, even before symptoms appear or tumors are visible on imaging. This is crucial for improving survival rates and treatment outcomes.

2. Monitoring Treatment Effectiveness

By tracking CTC blood test results, doctors can assess how well a patient is responding to treatment. For example, a decrease in CTC levels often indicates successful therapy.

3. Personalized Cancer Therapy

The CTC Test evaluates how cancer cells respond to specific treatments, such as chemotherapy or immunotherapy. This information helps doctors tailor personalized treatment plans for better outcomes

 

Who Should Consider CTC Testing?

• Individuals with a family history of cancer or elevated risk factors (e.g., smoking, obesity).
• Those seeking proactive Early Cancer Detection through advanced cancer screening methods.
• Patients undergoing cancer treatment who need to monitor their progress.

 

 

CTC Testing Process

1. Consultation : Review medical history and test details with a healthcare provider.
2. Blood Draw : A simple blood sample is collected.
3. Lab Analysis : Samples are processed in ISO-certified labs using advanced flow cytometry.
4. CTC Test Report：A detailed CTC Test report is generated, highlighting the presence and quantity of circulating tumor cells.
5. Results Interpretation：Your doctor will explain the CTC Test results and recommend appropriate next steps, such as further testing or treatment adjustments.

 

CTC Test Price and Accessibility

• CTC Test Price: The cost typically ranges from 10,000to 20,000 HKD, depending on the provider and location.
• CTC Test Registration: Many hospitals and specialized clinics offer CTC Test services. You can easily register online or by contacting a healthcare provider
• CTC Test  Near Me: To find a CTC Test  facility near you, search for “CTC Test  near me” or consult your local cancer center.

 

 

The Importance of Early Cancer Detection

Early Cancer Detection is critical for improving survival rates and reducing treatment complexity. Studies show that catching cancer early significantly increases the chances of successful treatment. For example:

• Early Detection of Cancer Statistics: Patients diagnosed at an early stage have a 5-year survival rate of over 90% for many cancers. 
• Does Early Detection of Cancer Save Lives?: Yes, early detection can lead to less aggressive treatments and better quality of life.

 

 

Future Prospects

The CTC Test  is poised to revolutionize cancer care by integrating with AI and other advanced technologies. This will enhance its accuracy and expand its applications in Early Cancer Detection and personalized treatment.

 

Conclusion

TheCTC Test  is a groundbreaking tool for Early Cancer Detection, offering high accuracy, non-invasive testing, and personalized insights. Whether you’re at risk for cancer or currently undergoing treatment, the  CTC Test can provide valuable information to guide your healthcare decisions.

 

Contact us to learn more about CTC testing services.

 

References:

• • Hospital Authority Hong Kong Cancer Registry (2022 data).
  • Papasotiriou et al. (2015). Journal of Cancer Therapy. 
  • Cristofanilli, M., Budd, G. T., Ellis, M. J., et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England Journal of Medicine, 351(8), 781-791. https://doi.org/10.1056/NEJMoa041993
  • Nagrath, S., Sequist, L. V., Maheswaran, S., et al. (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature, 450(7173), 1235-1239. https://doi.org/10.1038/nature06385
  • Pantel, K., & Alix-Panabières, C. (2010). Circulating tumor cells in cancer patients: Challenges and perspectives. Trends in Molecular Medicine, 16(9), 478-485. https://doi.org/10.1016/j.molmed.2010.07.001
  • Alix-Panabières, C., & Pantel, K. (2016).Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.Cancer Discovery  
  • World Health Organization (WHO).Cancer: Early Diagnosis and Screening.https://www.who.int/cancer/prevention/diagnosis-screening/en/

 

*Disclaimer:  The content of this article is provided solely for general informational, educational, and reference purposes and is not intended for medical diagnosis, treatment, or as a substitute for professional medical advice. Always consult a qualified medical doctor or healthcare provider for any health-related concerns, individualized diagnosis, or treatment plans.